Financial Performance - The company's revenue for Q3 2025 reached ¥2,219,425,314.62, representing a year-over-year increase of 31.60%[4] - Net profit attributable to shareholders for the same period was ¥282,078,974.99, up 47.84% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥270,775,455.57, reflecting a 45.42% increase year-over-year[4] - Total operating revenue for the current period reached ¥5,751,865,530.03, an increase of 17.6% compared to ¥4,889,154,064.91 in the previous period[20] - Net profit for the current period was ¥745,359,579.52, representing a 20.7% increase from ¥617,451,411.41 in the previous period[21] - The total revenue attributable to the parent company's owners was approximately ¥669.8 million, an increase from ¥585.7 million in the previous period, representing a growth of about 14.5%[22] - Basic and diluted earnings per share both increased to ¥2.55 from ¥2.10, reflecting a growth of approximately 21.4%[22] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥12,233,124,220.71, a 14.27% increase from the end of the previous year[4] - The total assets increased to ¥12,233,124,220.71, compared to ¥10,705,210,879.03 in the previous year, reflecting a growth of 14.2%[18] - Total liabilities rose to ¥2,881,652,408.36, up from ¥1,905,063,981.52, indicating a growth of 51.2%[18] - The total liabilities and equity reached ¥12,233,124,220.71, up from ¥10,705,210,879.03, indicating a growth of 14.2%[18] Shareholder Information - The total number of common stock shareholders at the end of the reporting period is 28,910[11] - The largest shareholder, Luo Jie, holds 22.43% of shares, totaling 66,093,066 shares[11] - The total number of restricted shares at the end of the period is 90,071,820, down from 126,836,056, indicating a reduction of approximately 29%[13] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥764,572,100.73, a significant increase of 796.97%[4] - Net cash flow from operating activities was ¥764.6 million, significantly up from ¥85.2 million in the previous period, indicating a substantial improvement in operational efficiency[23] - Cash inflow from operating activities totaled ¥7.06 billion, compared to ¥5.28 billion in the prior period, marking an increase of approximately 33.9%[23] - Cash outflow from investing activities was ¥389.5 million, slightly higher than ¥368.9 million in the previous period, resulting in a net cash flow from investing activities of -¥385.9 million[23] - Cash inflow from financing activities was ¥387.7 million, down from ¥659.2 million in the previous period, indicating a decrease of approximately 41.1%[23] - The net cash flow from financing activities was -¥126.8 million, an improvement from -¥422.8 million in the previous period, showing a reduction in cash outflow[23] - The ending balance of cash and cash equivalents was ¥3.58 billion, an increase from ¥3.04 billion at the end of the previous period, reflecting a growth of approximately 17.6%[23] Expenses - Research and development expenses for the year-to-date were ¥126,104,846.20, up 51.88% from the previous year[9] - The company reported a 90.14% increase in management expenses, totaling ¥322,580,168.01, primarily due to business growth and increased personnel costs[9] - Research and development expenses for the current period were ¥126,104,846.20, an increase from ¥83,027,149.77 in the previous period, reflecting a growth of 52.0%[20] Other Financial Metrics - The weighted average return on equity was 3.06% for the reporting period, an increase of 0.83% compared to the previous year[4] - The company reported a decrease in other comprehensive income, with a net amount of -¥81,350,213.23 compared to -¥31,751,486.64 in the previous period[21] - The company's financial expenses showed a significant improvement, with a net financial cost of -¥17,411,801.09 compared to -¥29,324,688.16 in the previous period[20] Investments and Projects - The company has established a joint venture, New Cheng New Energy Investment Co., Ltd., and is currently conducting construction for a project with an annual capacity of 30,000 tons of copper and 2,000 tons of cobalt[14] Audit and Accounting Standards - The company did not undergo an audit for the third quarter financial report[24] - The company plans to implement new accounting standards starting in 2025, which may impact financial reporting[24]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥181,523,113.69, representing a year-on-year increase of 12.81%[5] - Net profit attributable to shareholders for Q3 2025 was ¥39,757,302.73, up 10.30% compared to the same period last year[5] - The basic earnings per share for Q3 2025 decreased by 27.59% to ¥0.42[5] - Total revenue for the current period reached 499,685,945.74 yuan, up from 443,942,597.69 yuan in the previous period, representing an increase of approximately 12.5%[26] - Operating profit for the current period was 148,232,730.79 yuan, compared to 139,340,608.58 yuan in the previous period, indicating a growth of approximately 6.4%[27] - The company reported a net profit of 147,379,966.12 yuan for the current period, compared to 138,624,900.42 yuan in the previous period, representing an increase of about 6.3%[27] - The net profit for the current period is CNY 127,871,328.09, an increase from CNY 120,003,124.69 in the previous period, representing a growth of approximately 6.4%[28] - The net profit attributable to shareholders of the parent company is CNY 122,539,652.34, up from CNY 114,974,638.52, reflecting an increase of about 6.6%[28] - The total comprehensive income for the current period is CNY 127,572,670.00, compared to CNY 119,438,808.61 in the previous period, indicating a growth of around 6.5%[28] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥1,414,794,487.60, reflecting a 2.17% increase from the end of the previous year[5] - The company's total liabilities as of September 30, 2025, were 247,967,995.57 yuan, up from 229,990,176.73 yuan at the beginning of the period[24] - The company's equity attributable to shareholders increased by 0.60% to ¥1,151,307,201.66 compared to the end of the previous year[5] - The company's equity attributable to shareholders increased to 1,151,307,201.66 yuan from 1,144,437,207.45 yuan, reflecting a slight growth of about 0.6%[24] Cash Flow - Cash flow from operating activities for the year-to-date period decreased by 49.13% to ¥101,733,026.80[12] - Operating cash flow for the current period is CNY 101,733,026.80, down from CNY 199,974,270.11, a decrease of approximately 49.1%[29] - Cash inflow from investment activities is CNY 870,134,970.27, significantly higher than CNY 461,969,505.62 in the previous period, marking an increase of about 88.5%[30] - The net cash flow from investment activities is CNY 136,373,764.70, a recovery from a negative CNY 516,372,090.85 in the previous period[30] - The net cash flow from financing activities is negative CNY 132,706,684.92, compared to a positive CNY 463,439,155.82 in the previous period, indicating a significant decline[30] - The ending cash and cash equivalents balance is CNY 413,007,005.68, up from CNY 274,824,884.35, representing an increase of approximately 50.3%[30] Shareholder Information - The total number of common stock shareholders at the end of the reporting period is 7,274[14] - The largest shareholder, Zhang Wanwu, holds 29.46% of the shares, totaling 28,050,336 shares[14] - The second-largest shareholder, Zhang Ziheng, owns 19.83% of the shares, amounting to 18,876,404 shares[14] - The third-largest shareholder, Guo Yanzhi, possesses 18.64% of the shares, which is 17,743,820 shares[14] - The total number of unrestricted shares held by the top ten shareholders is 1,953,332[15] Research and Development - Research and development expenses for the current period were 26,083,984.27 yuan, compared to 20,648,168.00 yuan in the previous period, marking an increase of approximately 26.2%[27] Investments and Subsidiaries - The company established a wholly-owned subsidiary, Hebei Weina New Materials Co., Ltd., with an investment of 20 million yuan, completed registration on August 20, 2025[19] - The company reported a significant increase in receivables, with notes receivable rising by 907.31% to ¥5,861,019.77[9] - Investment income surged by 1020.43% to ¥4,199,609.62 for the year-to-date period[10] - The company reported a 1434.82% increase in fair value changes, amounting to ¥2,399,116.33 for the year-to-date period[10] Stock and Restricted Shares - The total number of restricted shares at the beginning of the period was 54,271,591, with 4,278,257 shares released during the period[18] - The total number of restricted shares at the end of the period is 71,400,000[18] - The company plans to release 8,014,382 restricted shares held by Zhang Wanwu on July 22, 2027[17] - Zhang Ziheng will have 5,393,258 restricted shares released on July 22, 2027[17] - The company has a strategic placement of 1,666,666 shares with a release date of July 22, 2025[18]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥3,101,554,351.09, representing a 165.53% increase year-over-year[5] - Net profit attributable to shareholders was ¥84,618,140.46, a staggering increase of 2,492.12% compared to the same period last year[5] - The basic earnings per share (EPS) was ¥0.1475, reflecting a 2,533.93% increase year-over-year[5] - The company reported a total profit of ¥259,179,635.84, which is a 2,463.09% increase year-over-year[9] - The company's net profit margin improved significantly, with profit total reaching ¥259,179,635.84 compared to ¥10,111,992.09 in the previous period[19] - The net profit for the current period is ¥187,773,017.03, compared to a net loss of ¥11,345,817.78 in the previous period[20] - The net profit attributable to shareholders of the parent company is ¥115,901,125.96, a significant improvement from a net loss of ¥14,415,775.85 in the previous period[20] - The total comprehensive income for the current period is ¥195,877,449.53, compared to a total comprehensive loss of ¥15,636,367.00 in the previous period[20] Cash Flow - The net cash flow from operating activities was ¥1,577,074,178.68, showing a significant increase of 703.05% compared to the same period last year[9] - Operating cash flow for the current period is ¥1,577,074,178.68, a recovery from a negative cash flow of ¥261,518,436.24 in the previous period[24] - Cash inflow from operating activities totaled ¥5,218,336,919.87, up from ¥4,097,657,478.77 in the previous period[24] - Cash outflow from operating activities decreased to ¥3,641,262,741.19 from ¥4,359,175,915.01 in the previous period[24] - The net cash flow from investing activities is ¥315,054,751.24, recovering from a negative cash flow of ¥155,036,428.92 in the previous period[24] - The net cash flow from financing activities is -¥1,894,449,680.00, compared to a positive cash flow of ¥160,308,041.43 in the previous period[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥10,570,860,524.61, a decrease of 26.66% from the previous year-end[5] - Current assets totaled ¥4,839,869,308.62, down from ¥8,118,432,068.34, indicating a decline of about 40.1%[18] - Current liabilities decreased to ¥5,555,071,098.38 from ¥8,419,130,169.53, a reduction of approximately 34.5%[18] - Non-current liabilities decreased to ¥1,012,378,513.33 from ¥2,122,342,299.89, reflecting a decline of about 52.3%[18] - The cash and cash equivalents at the end of the period were ¥1,600,259,511.76, slightly down from ¥1,603,828,169.93 at the beginning of the period[17] - The cash and cash equivalents at the end of the period amount to ¥1,588,840,530.89, slightly down from ¥1,497,103,500.40 in the previous period[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,623[10] - The largest shareholder, Nanjing Public Utilities Holdings Group Co., Ltd., holds 49.38% of shares, totaling 283,659,711 shares[10] - The second-largest shareholder, Nanjing Urban Construction Investment Holdings Group Co., Ltd., holds 4.69% of shares, totaling 26,930,936 shares[10] - The company has no preferred shareholders with voting rights[10] - The company has no preferred shareholders and no changes in the top ten shareholders due to margin trading activities[11] - The company has not identified any other relationships among the top ten shareholders beyond the first and second largest being acting in concert[11] Operational Highlights - The company’s gross profit margin improved significantly due to increased project deliveries, leading to higher operating profits[8] - The company experienced a 45.91% decrease in accounts receivable, primarily due to the collection of payments from a specific project[8] - The company reported a significant increase in sales expenses, which rose to ¥402,693,020.11 from ¥338,278,488.09, an increase of approximately 19.0%[19] - The company plans to participate in land use rights auctions for two plots in Nanjing, with one plot successfully acquired for RMB 1.323 billion[15] - The company received a total of RMB 22.25 million from a subsidiary during the reporting period[14] - The company has terminated the cash acquisition of a 68% stake in Hangzhou Yugu Technology Co., Ltd.[13] - The company’s subsidiary was authorized to bid for land use rights, indicating a strategy for market expansion[15] Cost Analysis - Total operating revenue for the period reached ¥5,968,318,839.29, a significant increase from ¥3,637,986,041.51 in the previous period, representing a growth of approximately 64.2%[19] - Total operating costs amounted to ¥5,781,394,808.58, up from ¥3,714,086,852.84, indicating an increase of about 55.5%[19] - Operating profit for the period was ¥256,021,257.23, compared to ¥13,350,083.09 in the previous period, reflecting a substantial improvement[19]

Financial Performance - The company's revenue for Q3 2025 was ¥543,456,419.92, representing a year-over-year increase of 7.18%[5] - The net profit attributable to shareholders was -¥21,302,733.89, a significant decline of 1,025.45% compared to the same period last year[5] - Total operating revenue for Q3 2025 reached CNY 1,593,014,097.66, an increase of 7.7% compared to CNY 1,478,923,011.81 in the same period last year[19] - Net profit for the period was a loss of CNY 310,248,602.63, compared to a loss of CNY 46,481,389.50 in the same quarter last year[19] - Basic and diluted earnings per share were both reported at -0.0173, compared to 0.0995 in the same quarter last year[19] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥175,121,559.93, showing an improvement of 81.67% from the previous year[11] - Operating cash flow for the current period was -175,121,559.93 CNY, an improvement from -955,575,497.94 CNY in the previous period[22] - Cash inflow from operating activities totaled 1,531,540,956.53 CNY, compared to 1,474,347,715.04 CNY in the prior year[22] - The company reported a net cash flow from investment activities of -244,872,397.40 CNY, an improvement from -918,868,799.42 CNY in the previous period[22] - The company’s cash outflow for financing activities was 54,933,251.68 CNY, down from 691,589,728.40 CNY in the previous period[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥6,210,880,638.20, reflecting a 3.13% increase from the end of the previous year[5] - Total liabilities increased to CNY 2,046,053,463.52, compared to CNY 1,526,185,458.97 in the previous year[18] - The equity attributable to shareholders of the parent company decreased to CNY 3,687,757,832.28 from CNY 3,730,544,275.59 year-on-year[18] - The company reported a significant increase in accounts payable, which rose to CNY 474,991,650.54 from CNY 303,326,595.53 year-on-year[18] Research and Development - Research and development expenses increased by 49.56% year-over-year, totaling ¥683,435,255.69, driven by enhanced investment in innovation[10] - Research and development expenses rose significantly to CNY 683,435,255.69, a 49.5% increase from CNY 456,957,233.20 in the previous year[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,410, with the largest shareholder holding 73.83% of the shares[12] - The company plans to increase its stake in Giant Bio by acquiring 29% of its shares for a cash consideration of RMB 1.1 billion, raising its ownership from 51% to 80%[14] - The acquisition of shares is expected to create greater value for all shareholders[14] Government Support - The company received government subsidies totaling ¥4,249,218.58 during the quarter, contributing to a year-to-date total of ¥71,944,745.16[6] Strategic Focus - The company is focused on enhancing its strategic layout in the innovative biopharmaceutical sector[14] - The company's financial position reflects a strong emphasis on managing liquidity and receivables effectively[16] - The ongoing acquisition process is being conducted in an orderly manner, with further details available on the company's official announcements[14]

Financial Performance - Q3 2025 revenue was CNY 118,274,679.35, a decrease of 7.82% year-over-year, while year-to-date revenue reached CNY 349,231,193.17, down 17.14% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was CNY 8,777,532.54, an increase of 123.57% year-over-year, with year-to-date net profit at CNY 24,044,095.67, up 156.55%[5] - The net profit excluding non-recurring items for Q3 2025 was CNY 15,177,917.20, a significant increase of 423.96% year-over-year, while year-to-date it was CNY 30,357,702.81, up 325.04%[5] - Total operating revenue for Q3 2025 was CNY 349,231,193.17, a decrease of 17.1% from CNY 421,468,424.66 in the same period last year[29] - Total operating costs for Q3 2025 were CNY 329,782,171.95, down 20.4% from CNY 413,928,591.21 in the previous year[29] - Net profit for Q3 2025 was CNY 23,445,300.50, compared to a net loss of CNY 44,632,335.57 in Q3 2024[30] - The company reported a gross profit margin of approximately 5.5% in Q3 2025, compared to a negative margin in the same quarter last year[30] Cash Flow and Assets - Cash flow from operating activities for the year-to-date period was CNY 71,345,913.50, an increase of 66.73%[5] - Cash flow from operating activities decreased by 45.21% to ¥5,479,561.18, due to a reduction in government subsidies and project guarantee recoveries[15] - Cash flow from investing activities showed a net outflow of ¥44,586,782.84, a significant increase of 276.57% compared to the previous period[16] - Cash and cash equivalents decreased by 1,765.19% to -¥130,310,349.72, primarily due to repayment of bank loans using internal funds[16] - The company's cash and cash equivalents decreased from CNY 247,949,011.09 to CNY 117,638,671.25, representing a decline of approximately 52.6%[27] - The ending balance of cash and cash equivalents was $117,020,731.28, down from $219,220,309.59[33] Investments and Income - The company recognized an investment income increase of CNY 31,291,100.00 from Shenzhen Yanghe Biomedical Industry Investment Co., Ltd. compared to the previous year[10] - Investment income increased by 244.16% to ¥18,710,906.35, reflecting a rise in fair value confirmation of investments[14] - Total profit rose by 167.56% to ¥27,926,751.64, driven by increased investment income and reduced losses from fair value changes of associates[14] - Cash received from investment income was $24,692,839.59, significantly higher than $1,614,986.41 in the previous period[33] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,504, with no preferred shareholders having restored voting rights[18] - The largest shareholder, Deng Guanhua, holds 15.91% of shares, with 36,895,916 shares pledged[18] - The total number of restricted shares decreased from 49,194,555 to 36,895,916 due to the release of shares held by executives[20] Cost Management and Efficiency - The company plans to continue focusing on cost control and efficiency improvements to mitigate the impact of declining revenues[10] - The company closed its wholly-owned subsidiary Guangzhou Ruida Medical Equipment Co., Ltd. as part of cost reduction efforts[23] - Financial expenses for the year-to-date period were CNY 3,213,416.02, down 58.46% compared to the previous year, primarily due to reduced interest expenses[13] Research and Development - The company has made significant investments in R&D to enhance product offerings and market competitiveness[22] - Research and development expenses for Q3 2025 were CNY 17,942,654.55, down 23.2% from CNY 23,376,301.59 in the same quarter last year[29] Asset Management - Total assets as of September 30, 2025, were CNY 1,079,746,419.77, a decrease of 13.21% from the end of the previous year[5] - The total assets decreased to CNY 1,079,746,419.77 from CNY 1,244,146,915.63, reflecting a decline of 13.2% year-over-year[29] - Total liabilities decreased to CNY 415,452,132.33 from CNY 600,282,029.67, a reduction of 30.7% compared to the previous year[29] - The company reported a total non-current asset balance of CNY 1,200,000,000.00 as of the end of the reporting period[27] Business Development - The company has established a joint venture named "联合生命" focusing on cell therapy and high-end health management, with operations commencing in the Hengqin area[25] - The company participated in several high-profile academic exchanges and exhibitions, showcasing key products like the specimen management system and intelligent blood collection management system[22] - The company aims to expand its localized service network, receiving high recognition from industry peers during recent conferences[22]

Financial Performance - The company's operating revenue for Q3 2025 was ¥487,314,942.88, representing a 17.01% increase year-over-year[4] - The net profit attributable to shareholders for Q3 2025 was ¥121,560,065.12, a decrease of 1.98% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥118,226,143.06, down 3.42% year-over-year[4] - The basic earnings per share for Q3 2025 was ¥0.3832, a decline of 2.04% compared to the previous year[4] - Total operating revenue increased to ¥1,408,508,921.66, up from ¥1,212,180,457.04, representing a growth of approximately 16.2% year-over-year[21] - Net profit for the period reached ¥414,136,383.70, compared to ¥350,176,798.69 in the previous period, reflecting an increase of about 18.3%[22] - Earnings per share increased to ¥1.3123 from ¥1.1297, representing a growth of about 16.2%[23] - Total comprehensive income for the period was ¥439,692,386.68, compared to ¥404,311,673.65 in the previous period, reflecting an increase of approximately 8.7%[23] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥4,274,678,179.23, an increase of 1.32% from the end of the previous year[4] - The total assets as of September 30, 2025, amounted to RMB 4,274,678,179.23, showing an increase from RMB 4,219,091,647.46 at the beginning of the period[19] - Current assets totaled RMB 2,290,216,007.66, up from RMB 1,872,526,148.78 at the beginning of the period[19] - Non-current assets decreased from RMB 2,346,565,498.68 to RMB 1,984,462,171.57 during the same period[19] - The total liabilities as of September 30, 2025, were RMB 1,416,413,004.15, down from RMB 1,487,447,856.57[19] - Total liabilities decreased slightly to ¥1,636,085,567.79 from ¥1,684,554,581.35, a reduction of about 2.9%[20] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥417,221,441.94, reflecting a significant increase of 52.52%[10] - Cash inflow from operating activities was ¥1,682,397,015.43, compared to ¥1,379,601,392.83 in the previous period, marking an increase of approximately 22%[24] - The net cash flow from operating activities was $417,221,441.94, an increase of 52.4% compared to $273,559,800.40 in the previous period[25] - Total cash outflow from operating activities amounted to $1,265,175,573.49, up from $1,106,041,592.43, reflecting a growth of 14.4%[25] - The net cash flow from investing activities was -$7,982,295.52, an improvement from -$10,665,758.43 in the prior period[25] - Cash inflow from investing activities totaled $427,759,960.17, compared to $401,935,501.58, marking a 6.4% increase[25] - Cash outflow from financing activities was $381,874,458.73, down from $512,284,641.39, indicating a reduction of 25.5%[25] - The net cash flow from financing activities was -$381,531,458.73, an improvement from -$498,714,135.19[25] - The ending balance of cash and cash equivalents was $657,164,273.97, compared to $733,928,011.35 in the previous period[25] - The company reported a cash increase of $27,209,186.51, contrasting with a decrease of $236,316,548.34 in the prior period[25] Member Growth - As of September 30, 2025, the total number of paid members on Made-in-China.com reached 29,214, an increase of 2,546 members compared to the same period last year[16] Dividends and Profit Distribution - The company plans to distribute cash dividends of RMB 6 per 10 shares, totaling RMB 190,341,521.40, based on a total share capital of 317,235,869 as of June 30, 2025[14] - The company has completed the profit distribution for the first half of 2025 without needing further shareholder approval[14] Other Financial Metrics - The weighted average return on equity was 4.78%, a decrease of 0.20% compared to the same period last year[4] - Research and development expenses rose to ¥133,582,866.72, up from ¥113,531,406.46, indicating a growth of approximately 17.6%[21] - Deferred income tax liabilities rose to ¥43,036,795.45 from ¥37,872,457.70, an increase of about 13.4%[20] - The total equity attributable to shareholders increased to ¥2,618,428,160.75 from ¥2,511,479,432.25, representing a growth of approximately 4.3%[20] - Other comprehensive income after tax decreased to ¥25,556,002.99 from ¥54,134,874.96, a decline of about 52.8%[22] Audit and Accounting Standards - The company did not undergo an audit for the third quarter financial report[26] - The new accounting standards will be first implemented starting in 2025[27]

Financial Performance - Q3 2025 revenue was CNY 214,175,464.62, a decrease of 0.57% year-over-year, while year-to-date revenue reached CNY 642,896,331.18, an increase of 12.68%[4] - The net profit attributable to shareholders for Q3 2025 was CNY -836,255.39, a decline of 166.90% year-over-year, and year-to-date net profit was CNY 359,527.98, down 93.05%[4] - The basic earnings per share for Q3 2025 was CNY -0.0024, a decrease of 166.67% compared to the same period last year, while year-to-date basic earnings per share was CNY 0.0010, down 93.33%[4] - The net profit for the current period was ¥388,922.26, a significant decrease of 92.91% from ¥5,488,971.65 in the previous period[19] - The company reported a total profit of ¥-570,806.95 for the current period, a decline from ¥2,564,681.69 in the previous period[19] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY -39,292,530.97, a significant decrease of 493.42% compared to the previous year[4][8] - The company reported a net cash outflow from operating activities of ¥39,292,530.97, compared to a smaller outflow of ¥6,621,418.77 in the previous period[20] - Cash and cash equivalents at the end of the period totaled ¥561,779,921.20, an increase from ¥539,562,853.88 at the end of the previous period[21] - The total cash inflow from financing activities was ¥591,346,255.00, compared to ¥365,146,108.09 in the previous period, indicating a 62.00% increase[21] - The company’s total cash outflow from investing activities was ¥200,373,309.00, significantly higher than ¥28,472,533.36 in the previous period[21] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 2,572,900,112.63, reflecting a 14.09% increase from the end of the previous year[4] - The total assets of Longlide Intelligent Technology Co., Ltd. increased from CNY 2,255,160,109.34 at the beginning of the period to CNY 2,572,900,112.63 at the end of the period, reflecting a growth of approximately 14%[16] - Current assets rose from CNY 1,204,038,389.87 to CNY 1,340,789,986.93, marking an increase of about 11.3%[15] - Total liabilities increased from CNY 831,445,160.63 to CNY 1,145,727,568.59, reflecting a growth of about 37.8%[17] - Long-term borrowings rose from CNY 286,918,052.89 to CNY 480,684,307.89, an increase of approximately 67.5%[17] Investment and Costs - The company reported a significant increase in project investment costs due to the ongoing construction of the Longlide Green Intelligent Cultural Innovation Project, impacting cash flow and profitability[8] - The company is currently in the investment phase for its new project, which has not yet begun production, leading to increased costs and reduced profitability[8] - Total operating costs increased to ¥660,989,350.35, up 13.38% from ¥583,132,991.85 in the previous period, with operating costs specifically rising to ¥550,904,713.68, a 12.00% increase[18] - The company incurred research and development expenses of ¥29,734,474.01, which is an increase of 18.66% from ¥25,178,448.13 in the previous period[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 17,562, with the largest shareholder holding 12.14% of the shares[10] - The total equity attributable to the parent company increased from CNY 1,418,212,879.99 to CNY 1,421,641,081.04, a slight increase of about 0.2%[17] Asset Composition - Cash and cash equivalents increased from CNY 577,733,443.96 to CNY 593,321,870.28, a growth of approximately 2.5%[15] - Accounts receivable decreased from CNY 182,235,212.26 to CNY 158,778,061.45, a decline of about 12.8%[15] - Inventory increased significantly from CNY 367,209,048.70 to CNY 472,178,019.01, representing a rise of approximately 28.6%[15] - The company reported a significant increase in fixed assets from CNY 792,535,598.48 to CNY 860,080,260.57, reflecting a growth of approximately 8.5%[16] - The company’s non-current assets increased from CNY 1,051,121,719.47 to CNY 1,232,110,125.70, indicating a growth of about 17.2%[16] Return on Investment - The weighted average return on net assets was -0.06% for Q3 2025, down from 0.03% in the previous year[4]

Financial Performance - Total revenue for Q3 2025 reached ¥741,287,436.95, an increase of 3.48% year-over-year[5] - Net profit attributable to shareholders was ¥1,681,675.27, representing a significant increase of 106.13% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥3,888,911.87, up 114.40% year-over-year[5] - Basic earnings per share for Q3 2025 was ¥0.01, reflecting a growth of 105.56% compared to the previous year[5] - Total operating revenue for the period reached ¥2,200,549,440.39, an increase from ¥2,136,699,863.80 in the previous period, representing a growth of approximately 3.9%[18] - Net profit for the period was ¥21,588,547.06, slightly down from ¥22,845,948.88, reflecting a decrease of approximately 5.5%[19] - The total comprehensive income for the period was CNY 21,588,547.06, compared to CNY 22,845,948.88 in the previous period[20] - Basic and diluted earnings per share remained stable at CNY 0.11 for both periods[20] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥4,606,956,437.82, a slight increase of 0.19% from the end of the previous year[5] - Total liabilities decreased to ¥2,465,547,256.68 from ¥2,476,861,122.42, a reduction of approximately 0.5%[17] - Total assets increased to ¥4,606,956,437.82 from ¥4,598,026,724.34, indicating a growth of about 0.2%[17] - Long-term equity investments increased to ¥207,109,185.61 from ¥170,089,374.50, reflecting a growth of about 21.8%[16] Cash Flow - Cash flow from operating activities for the year-to-date was ¥414,125,450.17, showing a slight decrease of 0.08% compared to the previous year[5] - The net cash flow from operating activities was CNY 414,125,450.17, slightly down from CNY 414,469,212.80 in the previous period[22] - Cash inflow from operating activities totaled CNY 2,236,276,463.31, an increase from CNY 2,184,953,764.81 year-over-year[22] - Net cash flow from investing activities decreased by 51.03% to -300,349,269.24 RMB, as all hospitals under construction have opened, leading to a significant reduction in fixed investments[10] - The net cash flow from investing activities was -CNY 300,349,269.24, improving from -CNY 613,278,600.03 in the previous period[23] - Cash and cash equivalents at the end of the period were CNY 376,140,370.20, down from CNY 479,822,198.29 at the end of the previous period[23] - The total cash outflow from financing activities was CNY 298,538,469.65, compared to CNY 606,582,850.80 in the previous period[23] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,438, with no preferred shareholders having restored voting rights[10] - Chengdu Puri Century Investment Co., Ltd. holds 35.91% of shares, amounting to 53,729,585 shares, with 24,941,200 shares pledged[10] - Xu Xuyang, a natural person, holds 6.75% of shares, totaling 10,100,000 shares, with 7,575,000 shares under lock-up[10] - The top ten shareholders collectively hold significant stakes, with the largest shareholder holding nearly 36% of the total shares[11] - The total number of unrestricted shares held by the top ten unrestricted shareholders is 78,829,585 shares[13] - The company has a high concentration of ownership, with the top shareholder being the actual controller of several management partnerships[11] - There are no preferred shareholders or changes in restricted shares reported for the current period[12] Operational Costs and Expenses - Total operating costs amounted to ¥2,105,665,391.88, up from ¥2,058,379,113.42, indicating an increase of about 2.3%[18] - Research and development expenses increased by 65.77% to ¥8,086,821.35, primarily due to higher IT R&D costs[9] - The company experienced a 295.01% decline in investment income, resulting in a loss of ¥2,523,117.09, mainly due to increased losses from joint ventures[9] - The company's cash and cash equivalents decreased to ¥376,140,370.20 from ¥481,067,596.27, a decline of about 21.8%[15] - Accounts receivable increased to ¥104,567,385.64 from ¥101,080,594.08, showing a growth of approximately 4.9%[15] - Inventory rose to ¥186,303,726.69 from ¥148,312,611.64, marking an increase of about 25.6%[16] - Total current assets slightly increased to ¥873,122,319.94 from ¥869,259,065.91, a growth of approximately 0.3%[16]

Financial Performance - The company's revenue for Q3 2025 was ¥327,026,036.48, a decrease of 1.79% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥13,089,580.55, down 1.32% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥12,680,673.21, an increase of 1.06%[5]. - The company's net profit for the first nine months of 2025 was ¥35,143,782.90, a decrease of 34.24% compared to the same period in 2024[8]. - Total operating revenue for Q3 2025 reached ¥971,141,619.09, an increase of 9.8% compared to ¥893,069,884.44 in the same period last year[20]. - Net profit for the period was ¥35,143,782.90, a decrease of 34.3% from ¥53,444,016.83 in the previous year[21]. - Total comprehensive income for the period was CNY 35,143,782.90, compared to CNY 53,444,016.83 in the previous period[22]. - Basic and diluted earnings per share decreased to CNY 0.1761 from CNY 0.2741 year-over-year[22]. Cash Flow - The operating cash flow net amount reached ¥101,554,515.42, representing a significant increase of 423.69% compared to the same period last year[5]. - Cash flow from operating activities generated a net cash inflow of CNY 101,554,515.42, a significant improvement from a net outflow of CNY -31,373,625.24 in the previous period[25]. - Cash inflow from investment activities totaled CNY 1,087,827,253.80, while cash outflow was CNY 1,122,741,207.93, resulting in a net cash outflow of CNY -34,913,954.13[25]. - Cash flow from financing activities resulted in a net cash outflow of CNY -106,039,756.24, compared to a net inflow of CNY 39,159,007.46 in the previous period[25]. - The company reported a significant increase in tax refunds received, amounting to CNY 23,614,023.68 compared to CNY 5,552,746.80 previously[25]. - The ending cash and cash equivalents balance was CNY 165,651,438.95, down from CNY 170,625,002.81 in the previous period[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,562,053,501.49, a decrease of 7.41% from the end of the previous year[5]. - The company's accounts receivable decreased to ¥472,964,904.36 from ¥612,184,094.80, reflecting a reduction of 22.7%[17]. - Inventory increased to ¥390,292,349.21, up 21.6% from ¥320,846,498.84 year-over-year[17]. - Total liabilities decreased to ¥388,534,875.29 from ¥528,477,307.13, a reduction of 26.5%[18]. - The company's equity attributable to shareholders increased to ¥1,166,230,338.42 from ¥1,151,720,097.57, a growth of 1.3%[18]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,663[10]. - The largest shareholder, Cheng Junming, holds 27.17% of the shares, totaling 53,508,000 shares[10]. - Shareholder Zhao Henglong owns 9.04% of the shares, equivalent to 17,808,280 shares[10]. - The company has a total of 244,843,000 shares under lock-up, with 53,508,000 shares held by Cheng Junming[12]. - The company plans to transfer 17,808,280 shares (9.04% of total shares) to Hantang Yunzhi Technology[13]. - Cheng Junming will relinquish voting rights for 53,508,000 shares (27.17% of total shares) upon the transfer of shares[13]. - The agreement for the transfer of shares includes a second phase where Cheng Junming intends to transfer an additional 25,522,956 shares (12.96% of total shares)[13]. - The voting rights relinquishment agreement is effective until the completion of the second phase transfer or 18 months after the first phase transfer[14]. Expenses - Sales expenses increased by 104.93% to ¥34,275,507.07 due to higher bidding costs associated with increased sales orders[8]. - Research and development expenses were ¥19,869,756.31, an increase of 7.3% compared to ¥18,517,582.73 in the previous year[21]. Other Information - The company reported a credit impairment loss of ¥11,108,360.85, compared to a gain of ¥8,861,841.78 in the previous year[21]. - The company did not undergo an audit for the third quarter financial report[26]. - The company plans to implement new accounting standards starting in 2025[26].

宸展光电（厦门）股份有限公司 2025 年第三季度报告 证券代码：003019 证券简称：宸展光电 公告编号：2025-064 宸展光电（厦门）股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季度报告中财务信 息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 宸展光电（厦门）股份有限公司 2025 年第三季度报告 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 669,121,660.72 | ...